Plasmodium Falciparum Clinical Trial
Official title:
A Phase 1 Clinical Trial To Evaluate The Safety and Infectivity Of Direct Venus Inoculation of Aseptic, Purified, Cryopreserved Plasmodium Falciparum 7G8 And NF54 Challenge Strains (PfSPZ) in a Head-To-Head Comparative Study
A comparison of Malaria events (symptoms and signs of malaria) experienced by subjects infected with PfSPZ Challenge (NF54) vs. PfSPZ Challenge (7G8).
The single center study is designed as a double-blind, randomized, placebo-controlled CHMI
trial with 2 parallel test groups to directly compare clinical and laboratory characteristics
of the NF54 and 7G8 strains of PfSPZ Challenge. This study will also evaluate signatures of
and time to parasitemia by multiple methods and evaluate physiologic status data collected by
non-invasive wearable monitors before and during Plasmodium falciparum infection to
characterize and trend physiologic changes appearing prior to the onset of parasitemia.
PfSPZ Challenge (aseptic, purified, cryopreserved, infectious Plasmodium falciparum
sporozoites) or normal saline will be administered by direct venous inoculation (DVI) by
25-gauge needle and syringe to healthy malaria naïve adults.
Data generated from samples collected for biomarker assay analysis will be useful for
developing predictive models to evaluate the efficacy of malaria vaccine candidates.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01935882 -
Low Dose Primaquine for Clearance of Gametocytes
|
Phase 2/Phase 3 | |
Completed |
NCT01775592 -
Plasmodium Falciparum Artemisinin Resistance Vietnam
|
Phase 4 | |
Completed |
NCT01728701 -
Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
|
Phase 1 | |
Completed |
NCT00914225 -
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
|
N/A | |
Completed |
NCT02895568 -
Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers
|
||
Completed |
NCT02259426 -
Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission
|
Phase 3 | |
Completed |
NCT01465048 -
Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe
|
N/A | |
Completed |
NCT00392015 -
NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1
|
Phase 1/Phase 2 | |
Completed |
NCT04661579 -
RTS,S/AS01E Hypo-immuno-responsiveness Study
|
Phase 2 | |
Recruiting |
NCT05400746 -
A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK
|
Early Phase 1 | |
Completed |
NCT03138096 -
Safety and Protective Efficacy of Pb(PfCS@UIS4)
|
Phase 1/Phase 2 | |
Completed |
NCT03452475 -
Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children
|
Phase 3 | |
Completed |
NCT00295581 -
PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria
|
Phase 1 | |
Completed |
NCT02418962 -
Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults
|
Phase 1 | |
Completed |
NCT01160562 -
Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity
|
||
Terminated |
NCT04445103 -
The Malaria Heart Disease Study
|
||
Completed |
NCT03132402 -
ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum
|
||
Completed |
NCT03172221 -
Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women
|
||
Not yet recruiting |
NCT03219281 -
Prevalence Survey of Antimalarial Drug Resistance Markers at Sites in India
|
N/A | |
Completed |
NCT02090036 -
Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of Gametocytes
|
Phase 4 |